Let me just follow up. I'm talking about the balance. I talked about protecting innovators.
On the other side, we want to make sure that Canadians continue to have full access to affordable medicines, and we are committed to that. That is why we're seeking a balanced outcome, and I believe Canadians will recognize that once negotiations are completed.